Effect of carbenoxolone on prostaglandin synthesis and degradation.
D000818:Animals; D001673:Biodegradation, Environmental / Q000187:drug effects; D002229:Carbenoxolone / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000201:enzymology / Q000378:metabolism; D006168:Guinea Pigs; D006637:Histamine N-Methyltransferase / Q000037:antagonists & inhibitors; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008168:Lung / Q000201:enzymology; D010084:Oxidation-Reduction; D011453:Prostaglandins / Q000096:biosynthesis / Q000378:metabolism*; D011460:Prostaglandins F / Q000378:metabolism; D014315:Triterpenes / Q000494:pharmacology*
D011453:Prostaglandins; D011460:Prostaglandins F; D014315:Triterpenes; D006911:Hydroxyprostaglandin Dehydrogenases; D006637:Histamine N-Methyltransferase; D002229:Carbenoxolone; D007213:Indomethacin